Condition
Long COVID Fatigue
Total Trials
4
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 4 (1)
Trial Status
Not Yet Recruiting3
Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT06980636Phase 4RecruitingPrimary
A Trial of Shengmai Liquid for Long COVID Fatigue.
NCT07312357Not ApplicableNot Yet Recruiting
Whole-Body Electrostimulation for Functional Recovery in Post-COVID Syndrome
NCT06992401Not Yet Recruiting
Observational Study of Intranasal IVIG in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Patients Undergoing Medical Tourism
NCT06992414Not ApplicableNot Yet RecruitingPrimary
Exploring the Therapeutic Effects of Creatine Supplementation for Long COVID-19
Showing all 4 trials